Clinical trial · Interventional
The MedMemos Study: Promoting Adherence to Medications in Pediatric Bone Marrow Transplant Patients
MedMemos: An Intervention to Promote Medication Adherence in Pediatric Allogenic Hematopoietic Stem Cell Transplantation
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this clinical trial is to test the MedMemos Intervention with parents and children who have received a bone marrow transplant. The main study questions are: * Is the MedMemos intervention acceptable to patients and families? * Is the MedMemos intervention feasible for patients, families, and healthcare providers? * Does MedMemos help patients and families take their medications better? Participants will be asked to complete surveys, attend 4 intervention sessions, and use an electronic box or pill bottle to store their medications in.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hematopoietic Cell Transplant | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| MedMemos | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- MedMemos
- description
- This arm will provide participants with the MedMemos Intervention
- interventionNames
- Behavioral: MedMemos
Primary outcomes (4)
- measure
- Intervention Acceptability
- timeFrame
- At the end of session 4 (An average of 14 days following the patient's hospital discharge, up to 28 days following discharge)
- description
- Intervention acceptability will be demonstrated by caregivers rating MedMemos a mean of ≥ 4 as measured on Acceptability of Intervention Measure, Feasibility of Intervention Measure, and Intervention Appropriateness Measure. Each measure asks participants to rate statements on a scale of "Completely Disagree" to "Completely Agree" Higher scores indicate greater acceptability, feasibility, and appropriateness.
- measure
- Intervention Feasibility - Percentage of patients who enroll out of those approached
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 0 Years
- Maximum age
- 12 Years
Show eligibility criteria text
Inclusion Criteria: * Child had a Pediatric Allogeneic Hematopoietic Cell Transplant (PAHCT) * Child is 0-12 years of age * At the time of recruitment child is still in the hospital for PAHCT * Child's primary caregiver is responsible for administering medical care and is willing to give consent to participate * Child is prescribed an oral medication regimen at discharge Exclusion Criteria: * Caregiver does not speak English, Spanish, or Arabic * Caregiver is not available to provide written permission for the child's participation * EMR or medical team report of the caregiver's cognitive status precludes completion of questionnaires * The child's medical status or condition precludes completion of the study questionnaires as determined by the physician or caregiver * Caregiver is unwilling to store medication in an electronic monitor
References
Publications (0)
Data not yet available